Case Report: Pelvic abscess formation secondary to the use of commercial hemostatic topical agent in an immunocompromised patient?
<p>Various hemostatic agents are currently available for routine laparoscopic procedures, avoiding thermal lesions due to energy devices and the complexity of intracorporeal sutures, however, evidence of complications in immunocompromised patients is still lacking. We present the case of a sev...
Salvato in:
Autori principali: | Mónica Monzón-Vargas (Autore), Yuliana Gómez- Meraz (Autore), Rodrigo Ayala-Yáñez (Autore) |
---|---|
Natura: | Libro |
Pubblicazione: |
Journal of Gynecological Research and Obstetrics - Peertechz Publications,
2017-07-03.
|
Soggetti: | |
Accesso online: | Connect to this object online. |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Documenti analoghi
-
Evaluating the risk of post-operative abscess formation following use of hemostatic agents at time of hysterectomy
di: Megan Howard, et al.
Pubblicazione: (2022) -
Lung abscess in immunocompromised
di: Teresa Margarida Dias Moreira, et al.
Pubblicazione: (2020) -
Achieving hemostasis in dermatology-Part II: Topical hemostatic agents
di: Jaimie B Glick, et al.
Pubblicazione: (2013) -
Medicinal Plants as Potential Hemostatic Agents
di: Fatemeh Ebrahimi, et al.
Pubblicazione: (2020) -
Pelvic floor abscess secondary to gossypiboma following a total Prolift procedure
di: Chung-Yu Chang, et al.
Pubblicazione: (2012)